Corbus Pharmaceuticals Holdings, Inc. Cash and Cash Equivalents
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Cash and Cash Equivalents of $23.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $23.37M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $25.66M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $28.49M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $26.98M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $23.37M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $25.66M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $28.49M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $26.98M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $20.04M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $18.90M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $17.20M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $19.42M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $23.69M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $14.10M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $13.72M 10-K · filed 2025-03-11 | $13.72M 10-K · filed 2024-03-12 |
| 2023-09-30 | $11.25M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $8.35M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $7.32M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $17.00M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $12.44M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $25.77M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $57.03M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $25.01M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $37.12M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $36.08M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $66.61M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $85.43M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $81.87M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $63.47M 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $46.62M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $31.75M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $54.85M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $73.15M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $89.92M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $41.75M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $55.66M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $64.68M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $70.96M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $62.54M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $36.60M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $43.03M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $48.93M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $14.99M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $18.91M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $22.03M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $9.69M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $12.34M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $13.17M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $9.24M 10-Q · filed 2016-08-12 | |
| 2015-03-31 | $4.97M 10-Q · filed 2016-05-13 | |
| 2014-12-31 | $6.26M 10-Q · filed 2016-11-10 | |
| 2014-09-30 | $7.54M 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $8.50M 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $163.04K 10-Q · filed 2015-05-13 | |
| 2013-12-31 | $303.02K 10-K · filed 2016-03-28 | |
| 2013-09-30 | $331.27K 10-Q · filed 2014-11-13 | |
| 2012-12-31 | $542.48K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |